Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block

British Journal of Anaesthesia

Volumn 77, Issue 3, 1996, Pages 424-426

  Naguib, M ^a,b   Samarkandi, A H ^a   Bakhamees, H S ^a   Turkistani, A ^a   Alharby, S W ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Antagonists, enzyme, plasma cholinesterase; Antagonists, neuromuscular block, edrophonium; Monitoring, neuromuscular function; Neuromuscular block, measurement of response; Neuromuscular block, mivacurium

Indexed keywords

CHOLINESTERASE; EDROPHONIUM; FENTANYL; ISOFLURANE; MIVACURIUM; NITROUS OXIDE; THIOPENTAL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MUSCLE FORCE; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULNAR NERVE;

EID: 0029740796     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.3.424     Document Type: Article

References (6)

1. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
2. Naguib M, Abdulatif M, Al-Ghamdi A, Hamo I, Nouheid R. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. British Journal of Anaesthesia 1993; 71: 709-914.
3. Naguib M, Daoud W, El-Gammal M, Ammar A, Turkistani A, Selim M, Altamimi W, Sohaibani MO. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase. Anesthesiology 1995; 83: 694-701.
4. Naguib M, Selim M, Bakhamees HS, Samarkandi AH, Turkistani A. Enzymatic versus pharmacologic antagonism of profound mivacurium-induced neuromuscular blockade. Anesthesiology 1996 ;84;1051-1059.
5. Pascuzzo GJ, Akaike A, Maleque MA, Shaw K-P, Aronstam RS, Rickett DL, Albuquerque EX. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Molecular Pharmacology 1984; 25: 92-101.
6. Naguib M, El-Gammal M, Daoud W, Ammar A, Moukhtar H, Turkistani A. Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade. Anesthesiology 1995; 82: 1288-1292.